Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Emerg Med ; 35(5): 803.e5-803.e6, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27912922

RESUMO

Infectious mononucleosis secondary to Epstein-Barr virus typically follows a relatively benign and self-limited course. A small subset of individuals may develop further progression of disease including hematologic, neurologic, and cardiac abnormalities. A mild transient neutropenia occurring during the first weeks of acute infection is a common finding however in rare cases a more profound neutropenia and agranulocytosis may occur up to 6weeks following the onset of initial symptoms. We describe the case of an 18-year-old woman who presented 26days following an acute infectious mononucleosis diagnosis with agranulocytosis and fever. No source of infection was identified and the patient had rapid improvement in her symptoms and resolution of her neutropenia. The presence of fever recurrence and other non-specific symptoms in individuals 2-6weeks following acute infectious mononucleosis symptom onset may warrant further assessment for this uncommon event.


Assuntos
Agranulocitose/etiologia , Antibacterianos/uso terapêutico , Infecções por Vírus Epstein-Barr/complicações , Febre/etiologia , Mononucleose Infecciosa/complicações , Ácido Penicilânico/análogos & derivados , Adolescente , Agranulocitose/tratamento farmacológico , Agranulocitose/terapia , Progressão da Doença , Infecções por Vírus Epstein-Barr/tratamento farmacológico , Feminino , Humanos , Mononucleose Infecciosa/tratamento farmacológico , Ácido Penicilânico/uso terapêutico , Piperacilina/uso terapêutico , Combinação Piperacilina e Tazobactam , Falha de Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...